4 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Treating Mucosal Candidiasis ... for effective treatment ... mucosal #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
Treatment includes ... prevention by minimizing ... #Vancomycin #AKI ... #pharmacology # ... diagnosis #management #nephrology
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
PO or IV q12h (AII ... course of primary treatment ... Bartonellosis #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
with positive serology ... mg/kg IV daily (AII ... Coccidiodomycosis #IDSA #Prevention ... #Treatment #management ... infections #HIVAIDS #pharmacology